Zaleplon

Insomnia Treatment

Zaleplon is used for the short-term treatment of insomnia. It belongs to a class of drugs known as sedative-hypnotics, which work by slowing brain activity to facilitate sleep.

Falling Asleep

The primary use of zaleplon is to help people who have difficulty with sleep onset, or the initial process of falling asleep. It is effective for:

• Initial sleep onset: Reducing the time it takes to fall asleep at the start of the night.
• Middle-of-the-night awakenings: Assisting with sleep if a person wakes up in the middle of the night and has trouble falling back to sleep, provided they still have several hours of sleep time remaining before they need to be active.

Because zaleplon is processed by the body very quickly, it is generally not used to increase the total duration of sleep or to prevent frequent awakenings throughout the night.

Short-Term Management

This medication is typically intended for temporary use, often for 7 to 10 days. It is used to manage sleep disturbances while underlying causes are being addressed or during periods of temporary stress. If sleep difficulties do not improve within this period, it may indicate the presence of another medical condition that requires evaluation.

Mechanism of Action

Zaleplon belongs to a class of medications known as sedative-hypnotics. It works by affecting certain natural chemicals in the brain that may be unbalanced in people with sleep problems, such as insomnia.

Specifically, zaleplon interacts with the GABA (gamma-aminobutyric acid) receptor complex in the central nervous system. GABA is a neurotransmitter that acts as a natural messenger to help calm brain activity. Zaleplon binds to these receptors to enhance the calming effects of GABA, which helps the brain transition into sleep more quickly.

Duration of Effect

Zaleplon is characterized by its very short half-life, meaning the body processes and eliminates the medication rapidly. Because it works quickly and does not stay in the system for a long time, it is primarily used to help with sleep onset (falling asleep) rather than helping a person stay asleep throughout the night.

Common Side Effects

• Drowsiness or daytime sleepiness
• Dizziness or lightheadedness
• Headache
• Coordination problems
• Nausea or stomach pain
• Muscle aches
• Tingling or numbness in the hands or feet
• Painful menstrual periods

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Complex sleep behaviors: Engaging in activities while not fully awake, such as sleep-walking, sleep-driving, making phone calls, or preparing and eating food.
• Severe allergic reactions: Hives, skin rash, swelling of the face, tongue, or throat, and difficulty breathing or swallowing.
• Mental health changes: New or worsening depression, anxiety, hallucinations, confusion, or thoughts of self-harm.
• Memory issues: Forgetting events that happened while the medication was active.
• Vision changes: Blurred vision or other changes in sight.

Older adults are at a higher risk for certain side effects, including confusion, dizziness, and an increased likelihood of falls and fractures.

Boxed Warning: Complex Sleep Behaviors

Zaleplon can cause serious and potentially fatal injuries due to complex sleep behaviors. These are activities performed while the person is not fully awake, such as sleepwalking, sleep-driving, preparing and eating food, or making phone calls. Because these behaviors occur while the individual is in a sleep-like state, they often have no memory of the event. If any complex sleep behavior occurs, the medication must be discontinued immediately and should not be taken again.

Contraindications

Zaleplon should not be used by individuals who have a history of experiencing complex sleep behaviors after taking zaleplon or other similar sedative-hypnotic medications, such as zolpidem or eszopiclone.

Severe Allergic Reactions

Rare but serious allergic reactions, including anaphylaxis and angioedema, have been reported. These reactions may involve swelling of the tongue, glottis, or larynx, which can lead to airway obstruction. Such reactions can occur as early as the first dose. Emergency medical assistance is necessary if symptoms of a severe allergic reaction develop.

CNS Depression and Next-Day Impairment

Zaleplon is a central nervous system (CNS) depressant that can impair mental alertness and motor coordination. There is a risk of next-day impairment, which may affect activities like driving or operating machinery. This risk is higher if the person does not get a full 7 to 8 hours of sleep after taking the dose, or if the medication is combined with alcohol or other drugs that cause drowsiness.

Abuse and Dependence

Zaleplon is a Schedule IV controlled substance, meaning it has the potential for abuse and may lead to physical or psychological dependence. The risk increases with higher doses and longer periods of use. Abruptly stopping the medication after several weeks of regular use may cause withdrawal symptoms, such as stomach cramps, muscle pain, shakiness, or seizures.

Mental Health and Suicidal Thinking

The use of sedative-hypnotics like zaleplon may lead to a worsening of depression or the emergence of suicidal thoughts and behaviors. Any unusual changes in mood, thinking, or behavior should be evaluated by a healthcare professional.

Other Precautions

• Respiratory Function: Caution is recommended for individuals with compromised respiratory function or chronic obstructive pulmonary disease (COPD).
• Liver Impairment: Because zaleplon is processed by the liver, individuals with liver disease may require a lower dose or may need to avoid the medication.
• Elderly Patients: Older adults may be more sensitive to the sedative effects of zaleplon, which can increase the risk of confusion and falls.

Pregnancy

There are no adequate and well-controlled studies of zaleplon in pregnant women. It is currently unknown whether zaleplon will cause harm to an unborn baby. Animal studies using high doses of the medication have shown some potential for adverse effects on offspring, but these results do not always predict how the drug will affect humans.

If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of using this medication with your healthcare provider.

Breastfeeding

Zaleplon passes into breast milk in small amounts. Because of the potential for sedative effects on a nursing infant, healthcare providers generally recommend that you do not breastfeed while taking this medication. You and your doctor should decide whether to continue breastfeeding or to take zaleplon, as doing both is typically discouraged.

Available Forms

Zaleplon is manufactured in the following dosage form:

• Oral Capsule: This medication is taken by mouth. It is typically used immediately before going to bed or after getting into bed and experiencing difficulty falling asleep.

The medication should be taken exactly as directed by a healthcare provider. It is intended for short-term use, and patients should only take it when they are able to stay in bed for a full night of sleep.

FDA Approval and Indication

Zaleplon is approved by the U.S. Food and Drug Administration (FDA) for the short-term treatment of insomnia. It is specifically indicated for patients who have difficulty falling asleep. Clinical use is generally limited to short periods, typically 7 to 10 days, as the safety and efficacy of long-term use have not been established.

Boxed Warning

The FDA has mandated a Boxed Warning for zaleplon because of the risk of complex sleep behaviors. These behaviors involve performing activities while not fully awake, such as:

• Sleepwalking
• Sleep-driving
• Cooking or eating food
• Making phone calls

These incidents can lead to serious injuries or death. If a patient experiences any complex sleep behavior, they must stop taking zaleplon immediately and contact their healthcare provider.

Controlled Substance Status

Zaleplon is classified as a Schedule IV controlled substance under the Controlled Substances Act. This classification means it has a recognized medical use but also carries a potential for abuse, misuse, and dependence. Patients should be monitored for signs of habit-forming behavior.

Safety Communications

The FDA has issued safety communications regarding the potential for next-day impairment. While zaleplon has a shorter half-life than some other sleep medications, patients may still experience decreased mental alertness or coordination the morning after use, which can affect tasks like driving.

How Zaleplon Treats Insomnia

Zaleplon is primarily used for the short-term management of sleep-onset insomnia, which is difficulty falling asleep. It belongs to a class of medications called sedative-hypnotics and works by slowing activity in the brain to allow sleep. Because it has a very short half-life, it is effective for helping people fall asleep quickly but is generally not used to help people stay asleep throughout the night.

Key aspects of its use for insomnia include:

• Short-term duration: It is typically prescribed for 7 to 10 days. Long-term use is generally not recommended without further medical evaluation.
• Middle-of-the-night use: It can be taken if someone wakes up in the middle of the night and has trouble returning to sleep, provided they can remain in bed for at least 4 more hours.
• Timing: The medication should be taken immediately before bed or after getting into bed. Taking it with or immediately after a high-fat meal may delay its effectiveness.

If insomnia symptoms do not improve within 7 to 10 days of treatment, it may suggest the presence of another medical or psychiatric condition that requires a different approach to care.